Chronic myeloid leukemia treatment guidelines: Brazilian Association of Hematology, Hemotherapy and Cell Therapy. Brazilian Medical Association Guidelines Project - 2012
AUTOR(ES)
Souza, Carmino Antonio de, Pagnano, Katia Borgia Barbosa, Bendit, Israel, Conchon, Monika, Freitas, Carla Maria Boquimpani de Moura, Coelho, Arthur Moellmann, Funke, Vaneuza Araújo Moreira, Bernardo, Wanderley Marques
FONTE
Rev. Bras. Hematol. Hemoter.
DATA DE PUBLICAÇÃO
2012
RESUMO
Documentos Relacionados
- Consensus of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy (ABHH) and the Brazilian Ministry of Health - General management of blood and blood products on the tests necessary for the release of exceptional medicines for sickle cell disease
- Guidance on diagnosis, prevention and treatment of thromboembolic complications in COVID-19: a position paper of the Brazilian Society of Thrombosis and Hemostasis and the Thrombosis and Hemostasis Committee of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy
- Guidelines on the diagnosis and management of multiple myeloma treatment: Associacao Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associacao Medica Brasileira - 2012
- The Guidelines Project: Brazilian guidelines for acute promyelocytic leukemia
- Bone marrow transplantation and acute myeloid leukemia: Brazilian guidelines
